跳至主要内容
临床试验/NCT00881686
NCT00881686已完成1 期

Study of Myocardial Protection in Pediatric Cardiac Surgery With Adenosine Preconditioning

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2008年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
238
试验地点
1
主要终点
Outcome Measure: all cause mortality

研究概览

简要总结

Adenosine has been proved to be an important mediator of myocardial protection induced by ischemic preconditioning. The hypothesis of this study is that adenosine preconditioning can provide additional myocardial protection in the setting of pediatric open heart surgery with cardioplegia and cardiopulmonary bypass.

详细描述

Adenosine has been used for diagnosis and treatment of cardiovascular diseases for many years. New progresses in myocardial protection in the settings of acute myocardial infarction treatment put forward the its clinical use to a broader field. But the safety and effectiveness of its use in myocardial protection in the setting of open heart surgery has not been investigated intensively. Our primary results suggested that adenosine preconditioning could decrease the release of myocardial serum markers, such as cTnI. This study will focus on the safety and effectiveness of adenosine in the field of pediatric myocardial protection during surgery repair of congenital heart defects with CPB and cardioplegia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Day 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of congenital heart defects eligible for surgery treatment under cardiopulmonary bypass and cardioplegia
  • Body weight less than or equals to 10kg

排除标准

  • Cardiac surgery is performed without cardiopulmonary or cardioplegia
  • Body weight more than 10Kg

研究组 & 干预措施

adenosine

Experimental

Adenosine will be administered intravenously before surgery

干预措施: adenosine (Drug)

结局指标

主要结局

Outcome Measure: all cause mortality

时间窗: within the first 30 days (plus or minus 3 days) after surgery

次要结局

  • The time of ICU stay(within the first 30 days (plus or minus 3 days) after surgery)

研究者

发起方
Xijing Hospital
申办方类型
Other

研究点 (1)

Loading locations...

相似试验